Taysha Gene Therapies, Inc. TSHA US — Non-Current Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Taysha Gene Therapies, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s us — non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s US — non-current assets?
- Taysha Gene Therapies, Inc. (TSHA) reported US — non-current assets of $0 in Q4 2025.
- What does US — non-current assets mean?
- This metric represents the total value of long-term assets held by the company within the United States geographic segment that are not expected to be converted to cash within one year. It typically includes property, plant, equipment, intangible assets, and long-term investments essential for supporting the company's domestic research and development infrastructure. Monitoring this figure helps investors assess the scale of long-term capital investment dedicated to the domestic market.